Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | MIF | P14174 | 1/20 | 0.31 |
| ▸ | TYR | P14679 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25763024 | 0.80 | ACHE (0.34) | ACHENR1H2NR1H3ALDH1A1ALOX15 | |
| SCHEMBL6059239 | 0.79 | NPC1 (0.41) | ALDH1A1SMN1; SMN2LMNAPOLB | |
| SCHEMBL17746559 | 0.75 | ACHE (0.35) | ACHENR1H2NR1H3ALDH1A1ALOX15 | |
| SCHEMBL18238741 | 0.70 | ACHE (0.40) | ACHENR1H2NR1H3GLAPOLB | |
| SCHEMBL13995130 | 0.69 | TRPA1 (0.35) | ACHEALDH1A1TSHR | |
| SCHEMBL2357462 | 0.69 | ALDH1A1 (0.48) | ALDH1A1ALOX15KDM4ECYP1A2MAPT | |
| SCHEMBL2997686 | 0.68 | ACHE (0.33) | ACHENR1H2NR1H3 | |
| SCHEMBL26569653 | 0.67 | PSMB5 (0.33) | NR1H2NR1H3ALDH1A1KDM4ECYP1A2 | |
| SCHEMBL12816608 | 0.67 | ADORA3 (0.35) | ALDH1A1 | |
| SCHEMBL5147698 | 0.67 | ALDH1A1 (0.36) | NR1H2NR1H3ALDH1A1ALOX15CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7294729-B2 | Bis-chelating ligand and use thereof in carbonylation processes | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2007-11-13 | — | — | US | claimed |
| US-20060058557-A1 | Bis-chelating ligand and use thereof in carbonylation processes | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC | 2006-03-16 | — | — | US | claimed |
| EP-1554293-A1 | BIS-CHELATING LIGAND AND USE THEREOF IN CARBONYLATION PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2005-07-20 | — | — | EP | claimed |
| WO-2004035595-A1 | BIS-CHELATING LIGAND AND USE THEREOF IN CARBONYLATION PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2004-04-29 | — | — | WO | claimed |
| US-7294729-B2 | Bis-chelating ligand and use thereof in carbonylation processes | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2007-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058557-A1 | Bis-chelating ligand and use thereof in carbonylation processes | CBR1, CBR3, AR | ACHE 3203/4885NR1H2 828/4885NR1H3 858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.